TickerFacts.

Company research / ADAG

Adagene Inc. (ADAG)

Build a valuation ↗↓ Download CSV

CIK 0001818838 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated E9
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Adagene Inc. reported revenue of $7.67M. Revenue grew 7332.8% from the prior annual period.

Key ratios (year ended 2025-12-31)

-279.5%
Operating margin
-229.6%
Net margin
-49.8%
Return on year-end equity
7332.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 4 · 2026-08-18

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue$7.67M$103.2K$18.11M$9.29M$10.18M$700.9K$480.0K$1.51M—
Operating Income-$21.44M-$35.95M-$23.72M-$83.92M-$72.36M-$43.15M-$19.17M-$17.33M—
Net Income-$17.61M-$33.42M-$18.95M-$79.97M-$73.18M-$42.40M-$16.43M-$15.27M—
EPS (Diluted)$-0.30$-0.59$-0.35$-1.48$-1.46$-2.67$-1.10$-0.94—
Total Assets$78.26M$89.27M$115.73M$152.40M$189.51M$84.26M$105.89M——
Total Liabilities$26.36M$38.74M$45.17M$69.31M$32.95M$19.20M$8.70M——
Shareholders' Equity$35.35M$50.52M$70.56M$83.09M$156.56M-$89.39M-$57.01M-$41.03M-$25.65M
Cash & Equivalents$74.52M$85.19M$109.93M$143.76M$174.39M$75.15M$92.53M——
Operating Cash Flow-$15.66M-$29.70M-$28.45M-$48.61M-$43.41M-$28.53M-$18.15M-$14.26M—
Capital Expenditures$17.1K$33.6K$85.0K$690.9K$2.51M$935.2K$151.8K$514.7K—
Shares Outstanding59.23M58.89M55.15M54.07M54.60M16.60M15.19M——
Weighted Average Diluted Shares59.01M56.29M54.74M54.14M50.03M15.95M15.18M15.16M—
EPS (Basic)$-0.30$-0.59$-0.35$-1.48$-1.46$-2.67$-1.10$-0.94—